Medacta Group 주식 주식분석 | 주식가격 | 뉴스 | MOVE.SW | CH0468525222 | A2PFTD

날짜	Medacta Group 주식 가격
	118.91 undefined
	118.04 undefined
	119.56 undefined
	122.11 undefined
	118.92 undefined
	116.67 undefined
	120.59 undefined
	118.46 undefined
	119.88 undefined
	120.73 undefined
	122.25 undefined
	119.90 undefined
	118.55 undefined
	119.35 undefined
	119.33 undefined
	120.97 undefined
	119.74 undefined
	119.38 undefined
	120.44 undefined
	120.56 undefined
	122.13 undefined

날짜	Medacta Group 매출	Medacta Group EBIT	Medacta Group 이익
2029e	1.09 조. undefined	249.63 백만 undefined	0 undefined
2028e	1.01 조. undefined	223.19 백만 undefined	0 undefined
2027e	852.81 백만 undefined	140.8 백만 undefined	109.79 백만 undefined
2026e	753.3 백만 undefined	124.42 백만 undefined	101.45 백만 undefined
2025e	672.16 백만 undefined	107.93 백만 undefined	86.57 백만 undefined
2024e	592.99 백만 undefined	90.72 백만 undefined	71.41 백만 undefined
2023	510.78 백만 undefined	75.72 백만 undefined	47.36 백만 undefined
2022	437.12 백만 undefined	68.94 백만 undefined	46.25 백만 undefined
2021	363.13 백만 undefined	66.59 백만 undefined	51.52 백만 undefined
2020	302.49 백만 undefined	48.82 백만 undefined	37.09 백만 undefined
2019	310.62 백만 undefined	57.81 백만 undefined	11.86 백만 undefined
2018	272.61 백만 undefined	61.51 백만 undefined	45.75 백만 undefined
2017	244.68 백만 undefined	49.66 백만 undefined	33.5 백만 undefined
2016	219.05 백만 undefined	49.5 백만 undefined	39.22 백만 undefined

	매출	EBIT	이익
2016	219.05 백만 EUR	49.5 백만 EUR	39.22 백만 EUR
2017	244.68 백만 EUR	49.66 백만 EUR	33.5 백만 EUR
2018	272.61 백만 EUR	61.51 백만 EUR	45.75 백만 EUR
2019	310.62 백만 EUR	57.81 백만 EUR	11.86 백만 EUR
2020	302.49 백만 EUR	48.82 백만 EUR	37.09 백만 EUR
2021	363.13 백만 EUR	66.59 백만 EUR	51.52 백만 EUR
2022	437.12 백만 EUR	68.94 백만 EUR	46.25 백만 EUR
2023	510.78 백만 EUR	75.72 백만 EUR	47.36 백만 EUR
2024e	592.99 백만 EUR	90.72 백만 EUR	71.41 백만 EUR
2025e	672.16 백만 EUR	107.93 백만 EUR	86.57 백만 EUR
2026e	753.3 백만 EUR	124.42 백만 EUR	101.45 백만 EUR
2027e	852.81 백만 EUR	140.8 백만 EUR	109.79 백만 EUR
2028e	1.01 조. EUR	223.19 백만 EUR	0 EUR
2029e	1.09 조. EUR	249.63 백만 EUR	0 EUR

2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e	2029e
0.22	0.24	0.27	0.31	0.3	0.36	0.44	0.51	0.59	0.67	0.75	0.85	1.01	1.09
-	11.42	11.48	13.97	-2.58	20.20	20.39	16.70	16.08	13.51	12.05	13.15	17.96	8.66
74.89	74.59	74.63	72.90	70.53	71.90	69.79	68.04	58.61	51.64	46.08	40.73	34.53	31.78
164	182	203	226	213	261	305	347	0	0	0	0	0	0
39	33	45	11	37	51	46	47	71	86	101	109	0	0
-	-15.38	36.36	-75.56	236.36	37.84	-9.80	2.17	51.06	21.13	17.44	7.92	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-
20	20	20	20	20	20	20	19.99	0	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-

2016	2017	2018	2019	2020	2021	2022	2023

21.21	25.12	33.95	27.5	49.37	20.4	33.06	27.84
36.08	36.89	44.09	48.05	45.78	59.44	77.96	94.65
2.02	2.89	4.16	7.42	5.42	7.86	7.21	6.85
67.36	72.51	89.23	101.63	114.19	136.09	160.3	213.92
2.31	1.88	3.2	3.19	2.95	4.25	5.13	5.2
128.96	139.29	174.62	187.79	217.7	228.03	283.66	348.47
100.87	101.53	132.91	157.45	153.36	179.75	218.5	267.34
391	364	765	456	488	479	481	712
8.19	11.82	0	0	0	0	0	0
13.49	31.85	39.94	45.53	48.74	51.92	50.13	51.36
0	59	59	59	59	59	59	59
17.78	14.91	17.31	21.28	21.59	29.03	31.66	27.94
140.72	160.52	190.97	224.78	224.24	261.23	300.83	347.4
269.68	299.81	365.6	412.56	441.94	489.27	584.49	695.87

0.99	0.99	1.78	1.78	1.78	1.78	1.78	1.78
0	0	0	21.23	21.23	21.23	16.02	10.49
142.97	112.93	93.03	102.89	139.41	192.36	239.88	282.32
2.91	-12.25	-5.74	-2.65	2.31	11.03	21.14	43.53
0	0	0	0	0	0	0	0
146.87	101.67	89.07	123.23	164.72	226.4	278.81	338.11
16.52	17.29	20.05	17.85	16.48	25.95	28.48	38.85
20.74	24.55	42.07	49.44	47.89	39.34	45.72	52.69
1.52	8.53	2.08	0.64	9.12	1.78	1.88	2.84
0	0	0	0	0	0	0	0
21.54	41.75	49.86	52.58	71.32	69.49	12.98	55.03
60.32	92.12	114.06	120.51	144.81	136.56	89.06	149.42
19.64	55.87	113.02	99.57	78.69	63.17	157.27	146.95
33.95	28.76	31.28	38.65	36.27	39.84	44.62	48.7
8.91	21.39	18.17	30.6	17.46	23.3	18.89	20.77
62.5	106.02	162.47	168.82	132.41	126.31	220.77	216.41
122.81	198.14	276.53	289.33	277.22	262.87	309.83	365.83
269.68	299.81	365.6	412.56	441.93	489.27	588.65	703.94

2016	2017	2018	2019	2020	2021	2022	2023
39	33	45	11	37	51	46	47
18	22	24	33	37	40	51	58
0	0	0	0	0	-4	0	0
-10	-19	-16	-10	-26	-53	-49	-60
9	15	11	7	12	15	25	29
0	0	0	2	1	1	2	5
7	4	4	3	8	25	8	8
56	51	66	42	59	54	73	75
-28	-40	-55	-51	-37	-54	-71	-82
-33	-44	-49	-42	-34	-52	-65	-80
-5	-4	5	9	3	2	6	1
0	0	0	0	0	0	0	0
-6	61	55	-32	-6	-29	16	4
0	0	0	21	0	-1	-2	-3
-9	-1	-9	-10	-6	-31	3	-10
-2.00	-62.00	-64.00	-	-	-	-10.00	-
0	0	0	0	0	0	0	-11
13	4	8	-6	20	-27	11	-11
28.02	11.47	11.28	-8.92	22.21	-0.56	2.25	-7.09
0	0	0	0	0	0	0	0

Medacta Group 브루토마진	Medacta Group 이익 마진	Medacta Group EBIT-마진	Medacta Group 이익 마진
2029e	68.1 %	22.86 %	0 %
2028e	68.1 %	22.21 %	0 %
2027e	68.1 %	16.51 %	12.87 %
2026e	68.1 %	16.52 %	13.47 %
2025e	68.1 %	16.06 %	12.88 %
2024e	68.1 %	15.3 %	12.04 %
2023	68.1 %	14.82 %	9.27 %
2022	69.83 %	15.77 %	10.58 %
2021	71.94 %	18.34 %	14.19 %
2020	70.72 %	16.14 %	12.26 %
2019	73.05 %	18.61 %	3.82 %
2018	74.82 %	22.56 %	16.78 %
2017	74.63 %	20.3 %	13.69 %
2016	75.12 %	22.6 %	17.9 %

	브루토마진	EBIT-마진	이익 마진
2016	75.12 %	22.6 %	17.9 %
2017	74.63 %	20.3 %	13.69 %
2018	74.82 %	22.56 %	16.78 %
2019	73.05 %	18.61 %	3.82 %
2020	70.72 %	16.14 %	12.26 %
2021	71.94 %	18.34 %	14.19 %
2022	69.83 %	15.77 %	10.58 %
2023	68.1 %	14.82 %	9.27 %
2024e	68.1 %	15.3 %	12.04 %
2025e	68.1 %	16.06 %	12.88 %
2026e	68.1 %	16.52 %	13.47 %
2027e	68.1 %	16.51 %	12.87 %
2028e	68.1 %	22.21 %	0 %
2029e	68.1 %	22.86 %	0 %

날짜	Medacta Group 주당 매출	Medacta Group EBIT 당 주식	Medacta Group 주당 이익
2029e	54.73 undefined	0 undefined	0 undefined
2028e	50.37 undefined	0 undefined	0 undefined
2027e	42.74 undefined	0 undefined	5.5 undefined
2026e	37.76 undefined	0 undefined	5.09 undefined
2025e	33.69 undefined	0 undefined	4.34 undefined
2024e	29.72 undefined	0 undefined	3.58 undefined
2023	25.55 undefined	3.79 undefined	2.37 undefined
2022	21.86 undefined	3.45 undefined	2.31 undefined
2021	18.15 undefined	3.33 undefined	2.58 undefined
2020	15.12 undefined	2.44 undefined	1.85 undefined
2019	15.53 undefined	2.89 undefined	0.59 undefined
2018	13.63 undefined	3.08 undefined	2.29 undefined
2017	12.23 undefined	2.48 undefined	1.67 undefined
2016	10.95 undefined	2.47 undefined	1.96 undefined

	주당 매출	EBIT 당 주식	주당 이익
2016	10.95 EUR	2.47 EUR	1.96 EUR
2017	12.23 EUR	2.48 EUR	1.67 EUR
2018	13.63 EUR	3.08 EUR	2.29 EUR
2019	15.53 EUR	2.89 EUR	0.59 EUR
2020	15.12 EUR	2.44 EUR	1.85 EUR
2021	18.15 EUR	3.33 EUR	2.58 EUR
2022	21.86 EUR	3.45 EUR	2.31 EUR
2023	25.55 EUR	3.79 EUR	2.37 EUR
2024e	29.72 EUR	0 EUR	3.58 EUR
2025e	33.69 EUR	0 EUR	4.34 EUR
2026e	37.76 EUR	0 EUR	5.09 EUR
2027e	42.74 EUR	0 EUR	5.5 EUR
2028e	50.37 EUR	0 EUR	0 EUR
2029e	54.73 EUR	0 EUR	0 EUR

	주식 수량
2016	20 백만 Aktien
2017	20 백만 Aktien
2018	20 백만 Aktien
2019	20 백만 Aktien
2020	20 백만 Aktien
2021	20 백만 Aktien
2022	20 백만 Aktien
2023	19.99 백만 Aktien
2024e	19.99 백만 Aktien
2025e	19.99 백만 Aktien
2026e	19.99 백만 Aktien
2027e	19.99 백만 Aktien
2028e	19.99 백만 Aktien
2029e	19.99 백만 Aktien

날짜	Medacta Group 배당금
2029e	0.31 undefined
2028e	0.31 undefined
2027e	0.31 undefined
2026e	0.31 undefined
2025e	0.31 undefined
2024e	0.31 undefined
2023	0.27 undefined
2022	0.27 undefined

	배당금	배당금 (추정)
2016	0 EUR	0 EUR
2017	0 EUR	0 EUR
2018	0 EUR	0 EUR
2019	0 EUR	0 EUR
2020	0 EUR	0 EUR
2021	0 EUR	0 EUR
2022	0.27 EUR	0 EUR
2023	0.27 EUR	0 EUR
2024e	0 EUR	0.31 EUR
2025e	0 EUR	0.31 EUR
2026e	0 EUR	0.31 EUR
2027e	0 EUR	0.31 EUR
2028e	0 EUR	0.31 EUR
2029e	0 EUR	0.31 EUR

날짜	Medacta Group 배당률
2029e	11.57 %
2028e	11.57 %
2027e	11.57 %
2026e	11.57 %
2025e	11.57 %
2024e	11.57 %
2023	11.57 %
2022	11.57 %
2021	11.57 %
2020	11.57 %
2019	11.57 %
2018	11.57 %
2017	11.57 %
2016	11.57 %

	배당률
2016	11.57 %
2017	11.57 %
2018	11.57 %
2019	11.57 %
2020	11.57 %
2021	11.57 %
2022	11.57 %
2023	11.57 %
2024e	11.57 %
2025e	11.57 %
2026e	11.57 %
2027e	11.57 %
2028e	11.57 %
2029e	11.57 %

%-지분	이름	주식	변경
69.61818 %	Family (Siccardi)	13,889,928	0
3.23441 %	Artisan Partners Limited Partnership	645,316	0
1.08623 %	GAM Investment Management (Switzerland) AG	216,720	0
1.07008 %	UBS Fund Management (Switzerland) AG	213,498	-875
0.91088 %	The Vanguard Group, Inc.	181,734	5,655
0.87942 %	SEB Asset Management (Denmark)	175,458	-424
0.75248 %	Norges Bank Investment Management (NBIM)	150,131	-8,223
0.66441 %	INVESCO Asset Management Limited	132,561	11,676
0.60242 %	Florida State Board of Administration	120,192	-31,674
0.59892 %	UBS Asset Management (Switzerland)	119,494	968
0.54365 %	Comgest S.A.	108,467	0
0.46097 %	MainFirst Asset Management	91,970	-36,712
0.41544 %	Franklin Templeton Investments Corporation	82,887	0
0.37324 %	UBS Asset Management Switzerland AG	74,468	-169
0.35662 %	Deka Investment GmbH	71,151	-24,200
0.35625 %	Z¿rcher Kantonalbank (Asset Management)	71,077	-2,766
0.31566 %	Schroder Investment Management (Switzerland) AG	62,980	-200
0.27473 %	BlackRock Institutional Trust Company, N.A.	54,812	31
0.27318 %	Dimensional Fund Advisors, L.P.	54,504	0
0.26691 %	Berenberg Bank (Asset Management)	53,253	3,331
0.23955 %	Bank J. Safra Sarasin AG (Asset Management)	47,795	0
0.16360 %	Braglia (Riccardo C)	32,640	-10,860
0.15036 %	Schroder & Co. Bank AG	30,000	3,000
0.14034 %	3V Asset Management AG	28,000	0
0.13533 %	Credit Mutuel Asset Management	27,000	0
0.11337 %	AEGON Investment Management B.V.	22,620	400
0.11281 %	BlackRock Advisors (UK) Limited	22,508	141
0.10137 %	CPR Asset Management	20,224	-1,192
0.10024 %	Bruellan Wealth Management	20,000	20,000
0.09592 %	Pictet Asset Management Ltd.	19,137	0
0.09423 %	VI Vorsorgeinvest AG	18,800	0
0.07337 %	Anima SGR S.p.A.	14,638	2,635
0.07247 %	Rieter Fischer Partners AG	14,459	0
0.06334 %	Charles Schwab Investment Management, Inc.	12,638	957
0.06015 %	Basler Kantonalbank	12,000	-1,000
0.05842 %	Union Bancaire Priv¿e	11,656	-23
0.05378 %	DWS Investment GmbH	10,730	740
0.05082 %	Berner Kantonalbank AG	10,140	0
0.04938 %	Templeton Investment Counsel, L.L.C.	9,852	0
0.04726 %	Dimensional Fund Advisors, Ltd.	9,429	0
0.04481 %	Valex Capital AG	8,941	0
0.04473 %	Valiant Bank AG	8,925	0
0.04260 %	VV Verm¿gensverwaltung AG	8,500	0
0.04258 %	Aargauische Kantonalbank	8,495	0
0.04110 %	Deka International S.A.	8,200	0
0.03859 %	Carnot Capital AG	7,700	7,700
0.03748 %	California State Teachers Retirement System	7,477	772
0.03668 %	Amundi (UK)	7,318	35
0.03178 %	Invesco Advisers, Inc.	6,340	0
0.03158 %	DWS International GmbH	6,301	0
0.02803 %	Geode Capital Management, L.L.C.	5,592	59
0.02701 %	Nuveen LLC	5,388	0
0.02560 %	Migros Bank Asset Management	5,108	0
0.02506 %	Reichmuth & Co.	5,000	0
0.02381 %	EFG Asset Management (UK) Limited	4,750	0
0.02345 %	Investas AG	4,678	0
0.02255 %	IFM Independent Fund Management AG	4,500	0
0.02186 %	EntrepreneurShares LLC	4,362	0
0.01951 %	IFS Independent Financial Services AG	3,893	0
0.01827 %	Amundi Asset Management, SAS	3,645	590
0.01754 %	Baumann & Cie KmG	3,500	-750
0.01373 %	BlackRock Asset Management Canada Limited	2,740	0
0.01314 %	LLB Swiss Investment AG	2,622	0
0.01289 %	Northern Trust Global Investments Limited	2,571	664
0.01276 %	State Street Global Advisors Ireland Limited	2,545	112
0.01253 %	Balli (Victor W.)	2,500	1,000
0.01180 %	Banque Cantonale Vaudoise	2,355	-5,330
0.01153 %	DWPT Deutsche Wertpapiertreuhand GmbH	2,300	0
0.01077 %	UBS Asset Management (UK) Ltd.	2,148	227
0.01016 %	Mercer Global Investments Management Ltd	2,028	0
0.00947 %	HanseMerkur Trust Swiss AG	1,890	0
0.00846 %	DFA Australia Ltd.	1,688	0
0.00826 %	State Street Global Advisors (US)	1,648	0
0.00791 %	BlackRock Investment Management (UK) Ltd.	1,579	0
0.00779 %	Vanguard Investments Australia Ltd.	1,555	1
0.00689 %	Handelsbanken Kapitalf¿rvaltning AB	1,375	0
0.00679 %	KLP Fondsforvaltning AS	1,354	0
0.00650 %	3 Banken-Generali Investment-Gesellschaft mbH	1,296	-345
0.00643 %	Pensofinance S.A.	1,283	0
0.00643 %	NS Partners Europe SA	1,283	0
0.00574 %	Banque Lombard Odier & Cie SA	1,145	951
0.00553 %	Mediolanum International Funds Limited	1,104	0
0.00501 %	Mayr Investment Managers GmbH	1,000	-100
0.00411 %	BCGE Asset Management	820	-145
0.00281 %	Legal & General Investment Management Ltd.	560	0
0.00248 %	State Street Global Advisors (France) S.A.	495	0
0.00200 %	chameleon asset management ag	400	0
0.00200 %	Evli Fund Management Company Ltd.	400	0
0.00189 %	Russell Investments Limited	377	0
0.00179 %	LLB Asset Management AG	357	0
0.00175 %	Nykredit Bank AS	349	0
0.00171 %	SEI Investments Management Corporation	341	-296
0.00168 %	Northern Trust Investments, Inc.	336	0
0.00164 %	Boston Partners	328	0
0.00163 %	Swiss Rock Asset Management AG	325	0
0.00150 %	House Of Wealth SA	300	0
0.00148 %	BG Fund Management Luxembourg S.A.	295	-7,504
0.00110 %	American Century Investment Management, Inc.	219	-1,650
0.00064 %	Vanguard Global Advisers LLC	127	0
0.00053 %	Eurizon Capital S.A.	106	106

What values and corporate philosophy does Medacta Group represent?

Medacta Group SA represents values of innovation, excellence, and patient-centricity in the healthcare industry. As a leading medical device company, Medacta focuses on developing and providing cutting-edge surgical solutions to enhance patient outcomes and improve the quality of life. The company's corporate philosophy revolves around collaboration, integrity, and a strong commitment to continuous improvement. Medacta strives to establish long-term partnerships with surgical teams, ensuring the highest standards of safety and efficiency. By consistently prioritizing patient well-being and leveraging its technological expertise, Medacta Group SA remains at the forefront of advancing medical advancements and delivering top-notch surgical solutions globally.

In which countries and regions is Medacta Group primarily present?

Medacta Group SA is primarily present in Europe, the United States, and Asia. The company has a strong presence in countries such as Switzerland, Italy, Germany, France, Spain, the United Kingdom, and the Netherlands. Additionally, Medacta Group SA has established a significant footprint in North America, with a focus on the United States. The company's presence in Asia includes countries like Japan, China, South Korea, Malaysia, and Singapore. Medacta Group SA's global presence enables it to provide its innovative medical solutions and orthopedic products to a wide range of healthcare professionals and patients around the world.

What significant milestones has the company Medacta Group achieved?

Medacta Group SA has achieved several significant milestones. Firstly, the company has successfully expanded its global presence, operating in over 50 countries worldwide. Additionally, Medacta Group SA has demonstrated continuous innovation in the field of medical devices and orthopedic solutions. The company has received numerous accolades for its cutting-edge technologies and advanced research initiatives. Medacta Group SA has also shown resilience during challenging times, maintaining steady growth in revenue and market share. Overall, the company's commitment to excellence and dedication to improving patient outcomes have positioned Medacta Group SA as a trusted leader in the healthcare industry.

What is the history and background of the company Medacta Group?

Medacta Group SA is a leading Swiss medical device company specializing in orthopedic products and services. Founded in 1999 by Dr. Alberto Siccardi, Medacta has grown to become a trusted player in the global healthcare industry. The company focuses on developing innovative solutions for joint replacement, spine surgery, and sports medicine. With a strong commitment to research and development, Medacta has revolutionized surgical approaches and attained international recognition. Medacta's dedication to providing surgeons with state-of-the-art tools and patients with improved outcomes has led to its global success. As a reputable supplier in the medical field, Medacta Group SA continues to strive for excellence in its products and services for the benefit of patients worldwide.

Who are the main competitors of Medacta Group in the market?

The main competitors of Medacta Group SA in the market are other companies in the orthopedic medical device industry, such as Zimmer Biomet Holdings Inc., Stryker Corporation, and Johnson & Johnson. These companies also specialize in producing and marketing orthopedic implants and surgical instruments. Medacta Group SA faces competition from these established players, but it differentiates itself through its innovative product offerings, strong focus on customer satisfaction, and dedication to continuous research and development. Its commitment to providing high-quality orthopedic solutions positions Medacta Group SA as a leading player in the market.

In which industries is Medacta Group primarily active?

Medacta Group SA is primarily active in the medical industry. As an innovative medical device company, Medacta specializes in developing and manufacturing orthopedic implants and surgical instruments. With a focus on personalized solutions, the company offers products for various medical procedures, including joint replacement, spine surgery, and sports medicine. Leveraging advanced technologies and research expertise, Medacta aims to improve patient outcomes and enhance surgical techniques. With its unwavering commitment to innovation and quality, Medacta Group SA has established itself as a prominent player in the medical field.

What is the business model of Medacta Group?

Medacta Group SA operates under a medical technology business model. As a leading manufacturer in the orthopedic industry, Medacta specializes in designing, developing, and distributing innovative surgical solutions. The company is primarily focused on providing integrated solutions for joint replacement, spine surgery, and sports medicine. Medacta aims to improve patient outcomes by offering a comprehensive range of products, including implants, instruments, and computer-assisted technologies. With a commitment to research and development, Medacta continuously pushes the boundaries of medical technology, enabling healthcare professionals to deliver advanced and personalized care to patients worldwide.

Medacta Group 2024의 P/E 비율은 얼마입니까?

Medacta Group의 P/E 비율은 33.29입니다.

Medacta Group 2024의 KUV는 얼마입니까?

Medacta Group의 P/S 비율은 4.01입니다.

Medacta Group의 AlleAktien 품질 점수는 얼마인가요?

Medacta Group에 대한 AlleAktien 품질 점수는 4/10입니다.

Medacta Group 2024의 매출은 얼마인가요?

예상되는 Medacta Group 매출은 592.99 백만 EUR입니다.

Medacta Group 2024의 이익은 얼마인가요?

예상되는 Medacta Group 이익은 71.41 백만 EUR입니다.

Medacta Group은 무엇을 하나요?

Medacta Group SA is a leading medical technology company specializing in the development, production, and marketing of innovative surgical solutions. The company operates globally and offers products and services in various business areas including orthopedics, spine, robotics, and traumatology. They also have expertise in digital health, offering solutions in telemedicine, risk management, and surgical planning. Their business model focuses on continuous improvement to provide high-quality products and collaborations with medical professionals to meet their needs. Through research and development, they aim to bring innovative technologies to the healthcare industry. Overall, Medacta Group SA offers a wide range of products and services tailored to the needs of healthcare professionals and patients, establishing themselves as a leading company in the medical technology industry.

Medacta Group 배당금은 얼마입니까?

Medacta Group은(는) 연간 번의 배당을 통해 0.27 EUR의 배당금을 지급합니다.

Medacta Group이 얼마나 자주 배당을 지급하나요?

Medacta Group의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Medacta Group ISIN이 무엇입니까?

Medacta Group의 ISIN은 CH0468525222입니다.

Medacta Group WKN은 무엇인가요?

Medacta Group의 WKN은 A2PFTD입니다.

Medacta Group 티커는 무엇인가요?

Medacta Group의 티커는 MOVE.SW입니다.

Medacta Group이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Medacta Group은(는) 0.27 EUR 의 배당금을 지급했습니다. 이는 약 0.23 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Medacta Group은(는) 0.31 EUR의 배당금을 지급할 것으로 예상됩니다.

Medacta Group의 배당 수익률은 얼마입니까?

Medacta Group의 현재 배당 수익률은 0.23 %입니다.

Medacta Group의 배당금은 언제 지급되나요?

Medacta Group은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Medacta Group의 배당금은 얼마나 안전한가요?

Medacta Group은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

Medacta Group의 배당금은 얼마입니까?

향후 12개월 동안 0.31 EUR의 배당금이 예상됩니다. 이는 배당수익률 0.26 %에 해당합니다.

Medacta Group이(가) 속해 있는 섹터는 어디인가요?

Medacta Group은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Medacta Group kaufen, um die vorherige Dividende zu erhalten?

Medacta Group의 마지막 배당금을 0.275 EUR만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Medacta Group의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Medacta Group의 2023년도 배당금은 얼마였습니까?

2023년에 Medacta Group는 0.268 EUR를 배당금으로 지급했습니다.

Medacta Group는 어떤 화폐로 배당금을 지급하나요?

Medacta Group의 배당금은 EUR에 지급됩니다.

Scope 1 - 직접 방출	393
스코프 2 - 구매한 에너지로부터의 간접적인 배출
Scope 3 - 가치 창출 체인 내의 간접 배출
총 CO₂ 배출량	393
CO₂ 감소 전략
석탄 에너지
원자력
동물 실험
펠츠 & 레더
살충제
팜 오일
담배
유전자 변형 생물체
기후 개념
지속 가능한 임업
재활용 규정
환경 친화적인 포장
위험물질
연료 소비량과 효율성
물 사용량 및 효율성

여성 직원 비율	30
관리 직위에서의 여성 비율
아시아 직원 비율
아시아 경영진 비율
히스패닉/라티노 직원 비율
히스패닉/라티노 관리 부문 지분
흑인 직원 비율
블랙 매니지먼트 지분
흰색 종업원의 비율
화이트 매니지먼트 지분
성인 콘텐츠
알코올
무기
총기
도박
군사 계약
인권 개념
개인정보 보호 정책
작업 및 건강 보호
카톨릭

환경 보고
이해관계자 참여
콜백 정책
카르텔법

증권거래소	Medacta Group 티커
뒤셀도르프	6MD.DU
프랑크푸르트	6MD.F
LONDON	0A05.L
LONDON STOCK EXCHANGE	0A05.L
뮌헨	6MD.MU
PNK	MEDGF
SIX	MOVE.SW

Medacta Group 티커	Medacta Group FIGI
MOVE:SW	BBG00NPRXKK9
MOVE:SE	BBG00NPRXKM7
MOVE:BW	BBG00NPRXKR2
6MD:GR	BBG00NS65PL1
6MD:GF	BBG00NS65PM0
6MD:GD	BBG00NS65PN9
6MD:GS	BBG00NS65PQ6
6MD:GM	BBG00NS65PR5
6MD:GB	BBG00NS65PS4
MOVECHF:XS	BBG00NSC9618
MOVECHF:XH	BBG00NSC9645
MOVECHF:XF	BBG00NSC9663
MOVECHF:XE	BBG00NSC9681
MOVECHF:XJ	BBG00NSC9690
MOVECHF:XL	BBG00NSC96B7
MOVECHF:XG	BBG00NSC96C6
MOVECHF:XO	BBG00NSC96D5
MOVECHF:XA	BBG00NSC96J9
MOVECHF:E1	BBG00NSC96K7
MOVECHF:XT	BBG00NSC96L6
MOVECHF:XW	BBG00NSC96M5
MOVECHF:XU	BBG00NSC96N4
MOVECHF:XV	BBG00NSC96P2
MOVECHF:XM	BBG00NSC96Q1
MOVECHF:XQ	BBG00NSC96R0
MOVECHF:XX	BBG00NSC96S9
MOVECHF:XZ	BBG00NSC96T8
MOVECHF:EU	BBG00NSC96W4
6MD:GZ	BBG00NSGB466
6MD:QT	BBG00NSGDJT6
MOVEEUR:XS	BBG00NSGV936
MOVEEUR:XH	BBG00NSGV963
MOVEEUR:XF	BBG00NSGV981
MOVEEUR:XE	BBG00NSGV9B7
MOVEEUR:XJ	BBG00NSGV9C6
MOVEEUR:XL	BBG00NSGV9D5
MOVEEUR:XG	BBG00NSGV9F3
MOVEEUR:XO	BBG00NSGV9G2
MOVEEUR:XA	BBG00NSGV9L6
MOVEEUR:E1	BBG00NSGV9M5
MOVEEUR:XT	BBG00NSGV9N4
MOVEEUR:XW	BBG00NSGV9P2
MOVEEUR:XU	BBG00NSGV9Q1
MOVEEUR:XV	BBG00NSGV9R0
MOVEEUR:XM	BBG00NSGV9S9
MOVEEUR:XQ	BBG00NSGV9T8
MOVEEUR:XX	BBG00NSGV9V5
MOVEEUR:XZ	BBG00NSGV9W4
MOVEEUR:EU	BBG00NSGV9Y2
MOVEZ:PO	BBG00NTLK008
MOVEZ:L3	BBG00NTLK080
MOVEZ:B3	BBG00NTLK0P1
MOVEZ:TQ	BBG00NWBCY92
MEDGF:US	BBG00NXBJTS4
MEDGF:PQ	BBG00NXBJV63
MEDGF:UV	BBG00NXBJV72
MOVECHF:X2	BBG00Q6T0NC8
0A05:LN	BBG00SYG7Q00
MOVEZ:L1	BBG00Y9251X7
MOVEZ:S1	BBG00Z4JJX21
MOVEZ:QX	BBG00Z8LGFR7
MOVEGBX:XS	BBG00Z9BP3L1
MOVEGBX:XH	BBG00Z9BP3P7
MOVEGBX:XF	BBG00Z9BP3R5
MOVEGBX:XE	BBG00Z9BP3T3
MOVEGBX:XL	BBG00Z9BP3W9
MOVEGBX:XG	BBG00Z9BP3X8
MOVEGBX:XO	BBG00Z9BP3Y7
MOVEGBX:XA	BBG00Z9BP420
MOVEGBX:XT	BBG00Z9BP448
MOVEGBX:XW	BBG00Z9BP457
MOVEGBX:XU	BBG00Z9BP466
MOVEGBX:XV	BBG00Z9BP484
MOVEGBX:XM	BBG00Z9BP493
MOVEGBX:EU	BBG00Z9BP4M8
MOVEZ:EB	BBG011JH6Y98
MOVEZ:IX	BBG011JH7199
6MD:LA	BBG018H9QMT5
6MD:LU	BBG018J3D5L5

한 눈에 저평가된 주식을 인식하세요

Medacta Group 주식 주식과 주식 분석 Medacta Group ariva, Medacta Group onvista, Medacta Group finanzen.net, Medacta Group aktienfinder, Medacta Group marketscreener, Medacta Group marketwatch, Medacta Group bloomberg, Medacta Group handelsblatt, Medacta Group wiwo, Medacta Group forum

가격

가격

티커MOVE.SW

ISINCH0468525222

WKNA2PFTD

Medacta Group 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Medacta Group 주가 이력

Medacta Group 주식 매출, EBIT, 이익 CH0468525222 · A2PFTD

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Medacta Group 매출, 이익 및 EBIT 역사

Medacta Group 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Medacta Group 주식 마진 CH0468525222 · A2PFTD

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Medacta Group 마진 역사

Medacta Group 주식 매출, EBIT, 주당 순이익 CH0468525222 · A2PFTD

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Medacta Group 매출, 이익 및 EBIT 주당 역사

Medacta Group 주식 및 주식 분석

한눈에 과소평가된 주식을 인식하세요.

Medacta Group Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Medacta Group 역사적인 P/E, EBIT 및 P/S에 따른 평가

한눈에 과소평가된 주식을 인식하세요.

Medacta Group 주식 수량 CH0468525222 · A2PFTD

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Medacta Group 주식 배당금 CH0468525222 · A2PFTD

배당금

배당금에 대한 개요

해석 및 사용

투자 전략

Medacta Group 배당금 내역

Medacta Group 주식 배당률 CH0468525222 · A2PFTD

배당비율

연간 배당비율이란 무엇인가요?

데이터 해석 방법

Medacta Group 주식
주식과 주식 분석 Medacta Group ariva, Medacta Group onvista, Medacta Group finanzen.net, Medacta Group aktienfinder, Medacta Group marketscreener, Medacta Group marketwatch, Medacta Group bloomberg, Medacta Group handelsblatt, Medacta Group wiwo, Medacta Group forum

티커
MOVE.SW

ISIN
CH0468525222

WKN
A2PFTD